Logo image of DHCNL

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

NASDAQ:DHCNL - Nasdaq - US25525P3055 - Currency: USD

14.3751  -0.05 (-0.38%)

Fundamental Rating

2

Taking everything into account, DHCNL scores 2 out of 10 in our fundamental rating. DHCNL was compared to 130 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHCNL have multiple concerns. DHCNL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

DHCNL had negative earnings in the past year.
In the past year DHCNL had a positive cash flow from operations.
DHCNL had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DHCNL reported negative operating cash flow in multiple years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a Return On Assets value of -7.21%, DHCNL is not doing good in the industry: 89.23% of the companies in the same industry are doing better.
DHCNL's Return On Equity of -18.90% is on the low side compared to the rest of the industry. DHCNL is outperformed by 86.15% of its industry peers.
Industry RankSector Rank
ROA -7.21%
ROE -18.9%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

DHCNL has a worse Gross Margin (17.31%) than 93.85% of its industry peers.
In the last couple of years the Gross Margin of DHCNL has declined.
The Profit Margin and Operating Margin are not available for DHCNL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
Compared to 1 year ago, DHCNL has a worse debt to assets ratio.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that DHCNL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.21, DHCNL is not doing good in the industry: 63.85% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.49 is on the high side and indicates that DHCNL has dependencies on debt financing.
DHCNL has a Debt to Equity ratio of 1.49. This is in the lower half of the industry: DHCNL underperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC6.93%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNL has a Current Ratio of 2.83. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL has a Current ratio of 2.83. This is amongst the best in the industry. DHCNL outperforms 86.15% of its industry peers.
DHCNL has a Quick Ratio of 2.83. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL has a better Quick ratio (2.83) than 86.15% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.83
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

DHCNL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.04%.
The Revenue has been growing slightly by 6.04% in the past year.
Measured over the past years, DHCNL shows a small growth in Revenue. The Revenue has been growing by 7.53% on average per year.
EPS 1Y (TTM)-14.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.28%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%5%

3.2 Future

Based on estimates for the next years, DHCNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.84% on average per year.
Based on estimates for the next years, DHCNL will show a small growth in Revenue. The Revenue will grow by 5.48% on average per year.
EPS Next Y24.97%
EPS Next 2Y16.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.73%
Revenue Next 2Y5.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

DHCNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DHCNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DHCNL is valued more expensive than 90.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.89
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as DHCNL's earnings are expected to grow with 16.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.84%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

DHCNL has a Yearly Dividend Yield of 1.78%.
With a Dividend Yield of 1.78, DHCNL pays less dividend than the industry average, which is at 16.87. 89.23% of the companies listed in the same industry pay a better dividend than DHCNL!
DHCNL's Dividend Yield is slightly below the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

The dividend of DHCNL decreases each year by -45.60%.
DHCNL has been paying a dividend for over 5 years, so it has already some track record.
DHCNL has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years2
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

DHCNL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.6%
EPS Next 2Y16.84%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (4/21/2025, 4:30:02 PM)

14.3751

-0.05 (-0.38%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners75.97%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap3.47B
Analysts44.44
Price Target12.34 (-14.16%)
Short Float %0.01%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.6%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-14 2025-02-14 (0.390625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.35%
Min EPS beat(2)-22.91%
Max EPS beat(2)107.62%
EPS beat(4)1
Avg EPS beat(4)8.41%
Min EPS beat(4)-27.3%
Max EPS beat(4)107.62%
EPS beat(8)3
Avg EPS beat(8)6.67%
EPS beat(12)3
Avg EPS beat(12)-9.02%
EPS beat(16)4
Avg EPS beat(16)-13.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)1.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)3
Avg Revenue beat(8)-0.59%
Revenue beat(12)4
Avg Revenue beat(12)-0.89%
Revenue beat(16)4
Avg Revenue beat(16)-1.46%
PT rev (1m)3.02%
PT rev (3m)-51.43%
EPS NQ rev (1m)12%
EPS NQ rev (3m)12%
EPS NY rev (1m)15.22%
EPS NY rev (3m)15.22%
Revenue NQ rev (1m)3.64%
Revenue NQ rev (3m)8.29%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.32
P/FCF N/A
P/OCF 30.91
P/B 1.77
P/tB 1.77
EV/EBITDA 26.89
EPS(TTM)-1.05
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.47
OCFY3.24%
SpS6.2
BVpS8.12
TBVpS8.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.21%
ROE -18.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.31%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Debt/EBITDA 12.53
Cap/Depr 70.78%
Cap/Sales 13.49%
Interest Coverage N/A
Cash Conversion 48.3%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 2.83
Altman-Z 0.21
F-Score5
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.28%
EPS Next Y24.97%
EPS Next 2Y16.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%5%
Revenue Next Year4.73%
Revenue Next 2Y5.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year365.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y970.52%
OCF growth 3YN/A
OCF growth 5Y-15.84%